Skip to main content

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Global Tuberculosis:Developing,Evaluating,Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally

Program Information

Popular name

N/A

Program Number

93.494

Program objective

CDC’s global health priorities include efforts towards ending the global tuberculosis (TB) epidemic by: expanding access to improved screening, contact tracing, and diagnostic tools to find the missing TB cases (FIND); optimizing treatment for TB and multi-drug-resistant (MDR) TB, including identifying and evaluating better treatment regimens, and expanding access to care and treatment (CURE); breaking the cycle of TB transmission by strengthening infection control, identifying TB hotspots to target screening, and scaling-up treatment to prevent TB (PREVENT); and helping countries strengthen their surveillance and laboratory systems, and workforce and research capacity to support sustainable health systems including promoting the wider use and adoption of recommended TB strategies and guidelines (SUSTAIN).

Program expenditures, by FY (2023 - 2025)

This chart shows obligations for the program by fiscal year. All data for this chart was provided by the administering agency and sourced from SAM.gov, USASpending.gov, and Treasury.gov.

For more information on each of these data sources, please see the About the data page.

Additional program information

Single Audit Applies (2 CFR Part 200 Subpart F):

For additional information on single audit requirements for this program, review the current Compliance Supplement.

OMB is working with the U.S. Government Accountability Office (GAO) and agency offices of inspectors general to include links to relevant oversight reports. This section will be updated once this information is made available.

Recipients must comply with the administrative and public policy requirements outlined in 45 CFR Part 75 and the HHS Grants Policy Statement, as appropriate.

  1. Pub. L. The United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2003; The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, Public Law 108-25; Public Law 110-293. Title 42 [42 USC] U.S.C. § Section 307 [42 USC 242l], as amended and Section 301(a) [42 USC 241(a)], as amended.

Program details

Categories & sub-categories

Education

Program types

Eligible beneficiaries

  • Anyone/general public
  • Artist/Humanist
  • Education Professional
  • Federal
  • Graduate Student
  • Health Professional
  • Individual/Family
  • Interstate
  • Local
  • Minority group
  • Other private institution/organization
  • Private nonprofit institution/organization
  • Profit organization
  • Quasi-public nonprofit organization
  • Scientist/Researchers
  • Small business
  • Specialized group (e.g. health professionals, students, veterans)
  • Sponsored organization
  • State
  • Student/Trainee
  • U.S. Territories

Additional resources